ESLAW vs MCK
Estrella Immunopharma Inc. (ESLAW) versus McKesson Corporation (MCK) — a side-by-side from cached financials, not a winner call.
Estrella Immunopharma Inc. (ESLAW) is a biotechnology company listed on US.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
ESLAW does not have a complete income-statement cache yet.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
ESLAW currently screens at market cap $0. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Not investment advice. Open the ESLAW and MCK stock pages for the full models.
Not investment advice.